Clinical Trials Directory

Trials / Completed

CompletedNCT03906019

Indications of Erector Spinae Plane Block in Pediatric Patients

Defining the Indications and Levels of Erector Spinae Plane Block in Pediatric Patients: A Retrospective Study About Our Current Experience

Status
Completed
Phase
Study type
Observational
Enrollment
141 (actual)
Sponsor
Kocaeli University · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers

Summary

Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned.

Detailed description

There are a few randomized prospective studies of ESPB for its clinical effectiveness and all of them are in adults, except one. Also pediatric case reports are limited when compared to adults. We have been applying ESPB to our patients almost since from its first definition. But ESPB applications for pediatric patients, in our clinic, have started after a learning curve. Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned. Demographical data of the patient, patient position for the block, indication/surgery type, level of ESPB, unilateral or bilateral application, total volume applied, additional analgesic use, type of the analgesic if used will be investigated.

Conditions

Interventions

TypeNameDescription
PROCEDUREESP BlockErector spinae plane block performed with 0,25% bupivacaine (0,5 mL/kg-max 20mL), under general anesthesia before the start of the surgery.
DIAGNOSTIC_TESTFLACC scoreFor up to 7 years old patients, Face, Legs, Activity, Cry and Consolability (FLACC) scores during postoperative 24h period.
DIAGNOSTIC_TESTNRS scorePatients older than 7 years, NRS scores during postoperative 24h period.

Timeline

Start date
2019-04-09
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2019-04-08
Last updated
2019-08-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03906019. Inclusion in this directory is not an endorsement.